FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

Device, Hemostasis, Vascular

PMA: P180025 · Supplement: S016 · Decision Apr 23, 2026
Classifications
1
FEI Numbers
0
Registration Numbers
0

Basic Information

Device Name
Device, Hemostasis, Vascular
Trade Name
MANTA™ Vascular Closure Device
PMA Number
P180025
Supplement Number
S016
Device Class
FDA Class 3
Product Code
MGB
Generic Name
Device, hemostasis, vascular
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
30-Day Notice Accepted
Decision Code
OK30
Decision Date
April 23, 2026
Date Received
March 23, 2026
Supplement Type
30-Day Notice
Supplement Reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

a change to the microbiology test laboratory location for the MANTA product family

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
MGB Device, Hemostasis, Vascular